SCHEMBL25026366

SCHEMBL25026366

CCC(C)(C(=O)OC)n1cc(C)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
LMNA P02545 2/20 0.34
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 2/20 0.34
HTT P42858 2/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
ALPI P09923 1/20 0.33
ALPG P10696 1/20 0.33
PLAA Q9Y263 1/20 0.33
CYP2C19 P33261 2/20 0.33
MAPK1 P28482 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
GAA P10253 1/20 0.31
CYP3A4 P08684 1/20 0.30
USP2 O75604 1/20 0.30
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25024913 0.84 CYP2C19 (0.32) CYP2C19
SCHEMBL13390165 0.82 HCRTR1 (0.38) ALDH1A1LMNAHSD17B10KDM4EHTT
SCHEMBL21086581 0.81 NOS1 (0.39) ALDH1A1LMNAHTTSMN1; SMN2ALPI
SCHEMBL13434308 0.76 ALPI (0.35) ALDH1A1LMNAHSD17B10KDM4EHTT
SCHEMBL16985332 0.76 CYP4F2 (0.45) ALDH1A1HSD17B10KDM4ETP53CYP2C19
SCHEMBL24354406 0.71 KDM4E (0.34) ALDH1A1LMNAHSD17B10KDM4ENOS1
SCHEMBL21086263 0.71 CYP4F2 (0.30)
SCHEMBL12837968 0.70 LMNA (0.44) ALDH1A1LMNAHSD17B10KDM4EALPI
SCHEMBL18645249 0.69 LRRK2 (0.41) ALDH1A1LMNAHSD17B10KDM4EHTT
SCHEMBL12693763 0.69 HCRTR1 (0.36) ALDH1A1HSD17B10TP53SMN1; SMN2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023016518-A1 HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 四川海思科制药有限公司 2023-02-16 WO disclosed